Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

NCT00138177 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage III Colon Cancer
Stage III Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: oxaliplatin
DRUG: leucovorin calcium
DRUG: vorinostat
DRUG: fluorouracil

Sponsor

National Cancer Institute (NCI)